These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 9103560)
1. Communication with the patient in clinical research. Zwitter M Ann N Y Acad Sci; 1997 Feb; 809():83-96. PubMed ID: 9103560 [No Abstract] [Full Text] [Related]
2. Translating the results of phase III randomized cancer trials into the language of physician obligation to patients. Markman M Curr Oncol Rep; 2004 Jul; 6(4):243-4. PubMed ID: 15161574 [No Abstract] [Full Text] [Related]
3. Phase I cancer trials. A collusion of misunderstanding. Miller M Hastings Cent Rep; 2000; 30(4):34-43. PubMed ID: 10971892 [No Abstract] [Full Text] [Related]
4. Improving informed consent in clinical trials: a duty to experiment. Lavori PW; Sugarman J; Hays MT; Feussner JR Control Clin Trials; 1999 Apr; 20(2):187-93. PubMed ID: 10227417 [TBL] [Abstract][Full Text] [Related]
5. Suspended judgment. Clinical trials of informed consent. Simel DL; Feussner JR Control Clin Trials; 1992 Oct; 13(5):321-4. PubMed ID: 1330436 [No Abstract] [Full Text] [Related]
6. Straight talking about cancer. Duty or danger? Verres R Ann N Y Acad Sci; 1997 Feb; 809():367-81. PubMed ID: 9103588 [No Abstract] [Full Text] [Related]
7. Physician-patient communication in phase I cancer trials. Nitschke R J Clin Oncol; 2004 Feb; 22(3):571-2; author reply 572-3. PubMed ID: 14752086 [No Abstract] [Full Text] [Related]
8. Medical research: why trouble the patient for informed consent? Farnell SM Med Pediatr Oncol; 2002 Sep; 39(3):207-9; discussion 210-1. PubMed ID: 12210453 [No Abstract] [Full Text] [Related]
9. Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective. Daugherty CK J Clin Oncol; 1999 May; 17(5):1601-17. PubMed ID: 10334550 [TBL] [Abstract][Full Text] [Related]
10. Seeking informed consent to cancer clinical trials: describing current practice. Brown RF; Butow PN; Ellis P; Boyle F; Tattersall MH Soc Sci Med; 2004 Jun; 58(12):2445-57. PubMed ID: 15081196 [TBL] [Abstract][Full Text] [Related]
11. Ethics of clinical trials from a bayesian and decision analytic perspective: whose equipoise is it anyway? Lilford RJ BMJ; 2003 May; 326(7396):980-1. PubMed ID: 12727776 [No Abstract] [Full Text] [Related]
12. Informed consent, the cancer patient, and phase I clinical trials. Daugherty CK Cancer Treat Res; 2000; 102():77-89. PubMed ID: 10650482 [No Abstract] [Full Text] [Related]
13. Transparency and self-censorship in shared decision-making. Brody H Am J Bioeth; 2007 Jul; 7(7):44-6. PubMed ID: 17654386 [No Abstract] [Full Text] [Related]
15. Informed consent for clinical treatment. Hall DE; Prochazka AV; Fink AS CMAJ; 2012 Mar; 184(5):533-40. PubMed ID: 22392947 [No Abstract] [Full Text] [Related]
16. The ethics of early stopping rules: who is protecting whom? Cannistra SA J Clin Oncol; 2004 May; 22(9):1542-5. PubMed ID: 15117977 [No Abstract] [Full Text] [Related]